KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to $2.17.

  • Incyte's EPS (Basic) rose 29454.55% to $2.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.04, marking a year-over-year increase of 345294.12%. This contributed to the annual value of $0.16 for FY2024, which is 9410.2% down from last year.
  • Latest data reveals that Incyte reported EPS (Basic) of $2.17 as of Q3 2025, which was up 29454.55% from $2.09 recorded in Q2 2025.
  • Incyte's EPS (Basic)'s 5-year high stood at $2.55 during Q4 2021, with a 5-year trough of -$2.04 in Q2 2024.
  • Over the past 5 years, Incyte's median EPS (Basic) value was $0.76 (recorded in 2023), while the average stood at $0.73.
  • Per our database at Business Quant, Incyte's EPS (Basic) surged by 127142.86% in 2021 and then tumbled by 32417.58% in 2024.
  • Over the past 5 years, Incyte's EPS (Basic) (Quarter) stood at $2.55 in 2021, then plummeted by 95.29% to $0.12 in 2022, then soared by 650.0% to $0.9 in 2023, then grew by 7.95% to $0.97 in 2024, then surged by 123.36% to $2.17 in 2025.
  • Its EPS (Basic) stands at $2.17 for Q3 2025, versus $2.09 for Q2 2025 and $0.82 for Q1 2025.